Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride
NDC Package 45802-721-62

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride is a . Marketed by Padagis Israel Pharmaceuticals Ltd, this product is identified by NDC 45802-721 and is authorized under FDA application ANDA077170.

Identification & Billing

NDC Package Code
45802-721-62
Package Description
24 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
45802-721
11-Digit Billing Format
45802072162
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
24 EA

Clinical Specifications

Proprietary Name
Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride
Dosage Form
-

Regulatory & Marketing

Labeler Name
Padagis Israel Pharmaceuticals Ltd
FDA Application #
ANDA077170
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-10-2008
End Marketing Date
06-01-2022
Listing Expiration
06-01-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (45802-721). Click a package code to view its specific billing and regulatory data.

45802-721-53
12 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45802-721-62 identifies a specific commercial package of 24 blister pack in 1 carton / 1 tablet, extended release in 1 blister pack of Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride, labeled by Padagis Israel Pharmaceuticals Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Padagis Israel Pharmaceuticals Ltd on April 10, 2008. The current certification is valid through June 01, 2022.

How is this Padagis Israel Pharmaceuticals Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802072162. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 24 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45802-721-62
11-Digit CMS (5-4-2)
45802-0721-62

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.